Letter from the Editor in Chief
- PMID: 37650122
- PMCID: PMC10464644
- DOI: 10.19102/icrm.2023.14086
Letter from the Editor in Chief
Conflict of interest statement
Dr. Mansour reports the reception of research grants from Abbott Laboratories, Biosense Webster, Johnson & Johnson, Boston Scientific, Medtronic, Pfizer, Boehringer Ingelheim, and SentreHeart. He is also a consultant for Abbott Laboratories, Biosense Webster, Johnson & Johnson, Boston Scientific, Janssen, Medtronic, Phillips, Novartis, and SentreHeart and reports an equity relationship with EPS Solutions. All aforementioned relationships are in the area of atrial fibrillation; Dr. Mansour additionally reports an equity relationship in the area of ventricular fibrillation with NewPace Ltd.
References
-
- Tonegawa-Kuji R, Nakai M, Kanaoka K, et al. Impact of low body mass index on cardiac tamponade during catheter ablation for atrial fibrillation. JACC Clin Electrophysiol. 2023;9(2):200–208. [CrossRef] [PubMed] - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources